NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Retinopathy of Prematurity


Return to Library

Free Retinopathy of Prematurity Articles


Studies from University of Gothenburg, Sahlgrenska Academy describe new findings in ophthalmology



2009 JUN 24 - (NewsRx.com) -- In this recent report, researchers in Gothenburg, Sweden conducted a study "To validate in a prospective study the surveillance algorithm WINROP for detecting infants at risk for proliferative retinopathy of prematurity (ROP). Fifty preterm infants with a mean gestational age of 26 weeks were included."

"In the first step of WINROP, weekly measures of body weight and serum insulinlike growth factor I (IGF-I) level from birth until postmenstrual age 36 weeks are entered and compared with expected development. If any of the variables show a negative deviation to a certain degree, an alarm is given. In the second step, gestational age, birth weight, and IGF binding protein 3 level are entered. The WINROP algorithm identified all children (100% sensitivity) who were diagnosed with proliferative ROP 1.1 to 21.6 weeks later. No infants with no alarm or with alarm at low risk developed proliferative ROP. Alarm at high risk before postmenstrual age 32 weeks was given for 22 of 50 infants (44%); 9 of these infants developed proliferative ROP (54% specificity), of whom 8 were treated," wrote C. Loqvist and colleagues, University of Gothenburg, Sahlgrenska Academy.

The researchers concluded: "The WINROP algorithm may be a useful tool for modification of ROP screening."

Loqvist and colleagues published their study in Archives of Ophthalmology (Validation of a New Retinopathy of Prematurity Screening Method Monitoring Longitudinal Postnatal Weight and Insulinlike Growth Factor I. Archives of Ophthalmology, 2009;127(5):622-627).

For additional information, contact C. Loqvist, University of Gothenburg, Sect Pediatrics Ophthalmology, Queen Silvia Children's Hospital, Sahlgrenska Academy, S-41685 Gothenburg, Sweden.

Publisher contact information for the journal Archives of Ophthalmology is: American Medical Association, 515 N State St., Chicago, IL 60610-0946, USA.

Keywords: Sweden, Gothenburg, Life Sciences, Proliferative Retinopathy, Pediatrics, Retinopathy of Prematurity, Neonatology, Therapy, Treatment, IGF I, Ophthalmology, University of Gothenburg, Sahlgrenska Academy.

This article was prepared by Fitness & Wellness Business Week editors from staff and other reports. Copyright 2009, Fitness & Wellness Business Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login